SE7500123L - - Google Patents

Info

Publication number
SE7500123L
SE7500123L SE7500123A SE7500123A SE7500123L SE 7500123 L SE7500123 L SE 7500123L SE 7500123 A SE7500123 A SE 7500123A SE 7500123 A SE7500123 A SE 7500123A SE 7500123 L SE7500123 L SE 7500123L
Authority
SE
Sweden
Application number
SE7500123A
Other versions
SE422064B (sv
Inventor
M A Kaplan
A P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7500123L publication Critical patent/SE7500123L/xx
Publication of SE422064B publication Critical patent/SE422064B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
SE7500123A 1974-01-07 1975-01-07 Forfarande for framstellning av 7-/d-alfa-amino-alfa-(p-hydroxifenyl)acetamido/-3-(1,2,3-triazol-5-yltimometyl)-3-cefem-4-karboxylsyra-1,2-propylenglykolat innehallande 1,0-1,6 mol 1,2-propylenglykol per mol... SE422064B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43125174A 1974-01-07 1974-01-07
US05/534,114 US3970651A (en) 1974-01-07 1974-12-18 Crystalline cephalosporin derivative

Publications (2)

Publication Number Publication Date
SE7500123L true SE7500123L (xx) 1975-07-08
SE422064B SE422064B (sv) 1982-02-15

Family

ID=27028950

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500123A SE422064B (sv) 1974-01-07 1975-01-07 Forfarande for framstellning av 7-/d-alfa-amino-alfa-(p-hydroxifenyl)acetamido/-3-(1,2,3-triazol-5-yltimometyl)-3-cefem-4-karboxylsyra-1,2-propylenglykolat innehallande 1,0-1,6 mol 1,2-propylenglykol per mol...

Country Status (17)

Country Link
US (1) US3970651A (xx)
JP (1) JPS6020394B2 (xx)
CA (1) CA1060886A (xx)
CH (1) CH612978A5 (xx)
DE (1) DE2500386C2 (xx)
DK (1) DK152368C (xx)
FI (1) FI66388C (xx)
GB (1) GB1483416A (xx)
HK (1) HK40981A (xx)
HU (1) HU168901B (xx)
IE (1) IE41883B1 (xx)
IL (1) IL46390A (xx)
KE (1) KE3150A (xx)
MY (1) MY8200099A (xx)
NL (1) NL185924C (xx)
OA (1) OA04876A (xx)
SE (1) SE422064B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
EP0018546B1 (en) * 1979-04-25 1983-09-28 BIOCHEMIE Gesellschaft m.b.H. Process for the production of phenylglycyl chloride hydrochlorides
IT1233864B (it) * 1988-02-24 1992-04-21 Opos Biochimica Srl Procedimento per la fabbricazione dell'acido 7-(d-(-)-alfa-amino-alfa -(p-idrossifenil)acetamido)-3-(1,2,3-triazol-4(5)-il)tiometil-3-cefem -4-carbossilico 1,2,-propilenglicolato e intermedio alogenato di detto procedimento
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
MXPA05000232A (es) * 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
CA2570949A1 (en) * 2006-12-12 2008-06-12 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
US7834195B2 (en) * 2007-01-24 2010-11-16 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
AR065809A1 (es) 2007-03-22 2009-07-01 Bristol Myers Squibb Co Formulaciones farmaceuticas que contienen un inhibidor sglt2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1316964A (en) * 1969-07-24 1973-05-16 Glaxo Lab Ltd Antibiotics
US3855213A (en) * 1971-02-18 1974-12-17 Smith Kline French Lab 3-heterocyclic thiomethyl-cephalosporins
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins

Also Published As

Publication number Publication date
GB1483416A (en) 1977-08-17
DK152368C (da) 1988-07-25
JPS6020394B2 (ja) 1985-05-21
NL7500167A (nl) 1975-07-09
FI66388B (fi) 1984-06-29
IL46390A (en) 1978-01-31
CH612978A5 (xx) 1979-08-31
DE2500386C2 (de) 1983-10-13
FI750002A (xx) 1975-07-08
IE41883L (en) 1975-07-07
DK152368B (da) 1988-02-22
CA1060886A (en) 1979-08-21
IE41883B1 (en) 1980-04-23
NL185924C (nl) 1990-08-16
DK692674A (xx) 1975-09-01
JPS50105813A (xx) 1975-08-20
NL185924B (nl) 1990-03-16
KE3150A (en) 1981-08-28
US3970651A (en) 1976-07-20
HU168901B (xx) 1976-08-28
OA04876A (fr) 1980-10-31
FI66388C (fi) 1984-10-10
MY8200099A (en) 1982-12-31
SE422064B (sv) 1982-02-15
IL46390A0 (en) 1976-06-30
HK40981A (en) 1981-08-28
DE2500386A1 (de) 1975-07-17

Similar Documents

Publication Publication Date Title
FR2293312B1 (xx)
FR2256882B1 (xx)
HU168901B (xx)
FR2293275B1 (xx)
JPS50103435A (xx)
FR2280216B3 (xx)
AU7099174A (xx)
AU7138274A (xx)
FI369374A (xx)
BG21632A1 (xx)
BG20983A1 (xx)
CH1107074A4 (xx)
BG26152A1 (xx)
BG23188A1 (xx)
BG19873A1 (xx)
BG22732A1 (xx)
BG22484A1 (xx)
BG22309A1 (xx)
BG22203A1 (xx)
BG22011A1 (xx)
BG21805A1 (xx)
DD117914A1 (xx)
BG21503A1 (xx)
BG21353A1 (xx)
BG21285A1 (xx)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500123-0

Effective date: 19950210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7500123-0

Format of ref document f/p: F